PHYSICS: Week 10

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

17 Terms

1
New cards

What is electron beam therapy and what is it used for?

  • External beam radiotherapy using high-energy electrons (6–20 MeV).

  • Treats superficial tumours (less than 5 cm deep).

  • Delivers relatively uniform dose followed by rapid fall-off.

  • Uses: Skin/lip cancer, breast chest wall, lymph node boosts, head and neck cancer.


2
New cards

How are electron beams produced in a LINAC?

  • Electron gun: Produces and injects electrons.

  • Waveguide: Accelerates electrons using microwaves.

  • Magnetron/Klystron: Generates/amplifies microwaves.

  • Electrons accelerated to MeV energies.


3
New cards

How are electron beams delivered compared with photon beams?

  • Photons: Electrons hit tungsten target → X-rays; flattening filter makes beam uniform.

  • Electrons: Scattering foil spreads electrons to create uniform beam.

  • Electron cones/applicators: Collimate beam close to patient (less than 5 cm).

  • Cones reduce penumbra caused by electron scattering.

  • Typical fields: 5 × 5 to 25 × 25 cm.


4
New cards

What are the four main electron interactions?

  • Inelastic collisions with electrons: Ionisation/excitation.

  • Inelastic collisions with nuclei: Bremsstrahlung.

  • Elastic collisions with nuclei: Nuclear Coulomb scattering.

  • Elastic collisions with electrons: Electron-electron scattering.

  • Inelastic = energy lost; elastic = direction changes with minimal energy loss.


5
New cards

What is stopping power?

  • Rate at which charged particles lose energy travelling through matter.

  • Collisional losses: Ionisation/excitation; depend on electron density.

  • Radiative losses: Bremsstrahlung; depend on \(Z^2\).

  • Total mass stopping power = collisional + radiative stopping power.

  • Electrons lose approximately 2 MeV/cm in water/soft tissue.


6
New cards

How is electron beam energy specified?

  • Initially narrow, almost monoenergetic beam (~3 mm).

  • Scattering and energy loss create a range of energies at the patient surface.

  • R₅₀: Depth in water where dose falls to 50% of maximum.

  • Mean surface energy: \(E_0=2.33R_{50}\) (MeV, with R₅₀ in cm).


7
New cards

What is the electron percentage depth dose (PDD) distribution?

  • Relatively high, uniform dose near the surface.

  • Rapid dose fall-off beyond therapeutic depth.

  • Small residual dose from bremsstrahlung contamination.

  • Advantage: Treats superficial tumours while sparing deeper tissues.


8
New cards

How is electron energy selected for tumour depth?

  • Choose energy to deliver 80–90% dose at tumour depth.

  • Approximate treatment depth (cm) = energy (MeV) ÷ 3–4.

  • Example: Tumour at 4 cm → approximately 12–16 MeV.

  • Higher energy = greater penetration.


9
New cards

How does increasing electron energy affect dose distribution?

  • Greater penetration depth.

  • Modest skin-sparing effect, which decreases with increasing energy.

  • Less rapid distal dose fall-off at higher energies.

  • Energies above 20 MeV generally less clinically useful.


10
New cards

What is the virtual source of an electron beam?

  • Electrons do not originate from one physical point like X-rays.

  • Scattered electrons appear to diverge from an imaginary virtual source.

  • Defined by back-projecting electron directions to their apparent origin.

  • Used to describe beam divergence and virtual SSD.


11
New cards

What factors affect electron treatment planning?

  • Usually uses a single field.

  • Energy/field size selected based on tumour depth and required dose.

  • Tissue inhomogeneities: Bone, lung and air alter dose distribution.

  • Oblique incidence/air gaps: Affect beam distribution.

  • Bolus: Tissue-equivalent material used to:

    • Increase surface dose.

    • Reduce penetration depth.

    • Flatten irregular surfaces.


12
New cards

What is total skin electron beam therapy (TSEBT)?

  • Irradiates the entire skin surface using low-energy electrons.

  • Commonly treats mycosis fungoides (skin lymphoma).

  • Patient usually stands during treatment.

  • Four or six fields from different angles provide body coverage.

  • Requires more complex dosimetry.


13
New cards

What is proton therapy and the Bragg peak?

  • External beam therapy using high-energy protons.

  • Bragg peak: Sharp maximum energy deposition at a specific depth.

  • Peak depth depends on proton energy.

  • Almost no dose deposited beyond the peak.

  • Allows tumour irradiation while sparing deeper healthy tissues.


14
New cards

What are the advantages of proton therapy?

  • Higher tumour dose with reduced normal tissue irradiation.

  • Lower integral dose than conventional X-ray therapy.

  • Reduced risk of radiation toxicity and secondary cancers.

  • Particularly useful for paediatric and complex head/neck tumours.


15
New cards

How are proton beams produced and delivered?

  • Clinical energies: 60–300 MeV.

  • Accelerated using cyclotrons or synchrotrons.

  • Pencil beam scanning:

    • Narrow proton beams (~3 mm).

    • Sweeper magnets scan across tumour.

    • Beam energy changes to control treatment depth.

    • Treatment planning system controls individual spot positions/doses.


16
New cards

What are the disadvantages of proton therapy?

  • Very expensive equipment and treatment facilities.

  • Large accelerators, beam transport systems and gantries.

  • Uncertainties in proton range.

  • Uncertainties in relative biological effectiveness (RBE).


17
New cards

How does carbon ion therapy compare with proton therapy?

  • Both use the Bragg peak for targeted dose delivery.

  • Carbon ions have higher linear energy transfer (LET).

  • Higher LET → denser ionisation → more severe DNA damage.

  • Potentially more effective for radio-resistant tumours.

  • Disadvantages:

    • More expensive than proton therapy.

    • Complex radiobiology and RBE uncertainties.

    • Range uncertainties and limited clinical trial evidence.